Axa S.A. raised its stake in Option Care Health, Inc. (NASDAQ:OPCH – Free Report) by 99.0% during the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 31,438 shares of the company’s stock after buying an additional 15,638 shares during the quarter. Axa S.A.’s holdings in Option Care Health were worth $871,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Parallel Advisors LLC grew its position in Option Care Health by 130.2% in the fourth quarter. Parallel Advisors LLC now owns 845 shares of the company’s stock worth $28,000 after acquiring an additional 478 shares in the last quarter. TFO Wealth Partners LLC lifted its position in shares of Option Care Health by 24,625.0% in the fourth quarter. TFO Wealth Partners LLC now owns 989 shares of the company’s stock worth $33,000 after buying an additional 985 shares during the last quarter. Park Place Capital Corp boosted its stake in shares of Option Care Health by 48.4% during the 1st quarter. Park Place Capital Corp now owns 1,140 shares of the company’s stock worth $38,000 after acquiring an additional 372 shares in the last quarter. SageView Advisory Group LLC acquired a new position in shares of Option Care Health during the 1st quarter valued at about $85,000. Finally, Blue Trust Inc. raised its stake in shares of Option Care Health by 14.8% in the 2nd quarter. Blue Trust Inc. now owns 2,931 shares of the company’s stock valued at $81,000 after acquiring an additional 377 shares in the last quarter. Hedge funds and other institutional investors own 98.05% of the company’s stock.
Insider Activity at Option Care Health
In other Option Care Health news, CFO Michael H. Shapiro sold 23,217 shares of the stock in a transaction on Thursday, August 22nd. The stock was sold at an average price of $30.95, for a total transaction of $718,566.15. Following the completion of the transaction, the chief financial officer now directly owns 247,317 shares in the company, valued at $7,654,461.15. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In other news, CFO Michael H. Shapiro sold 23,217 shares of Option Care Health stock in a transaction that occurred on Thursday, August 22nd. The shares were sold at an average price of $30.95, for a total value of $718,566.15. Following the completion of the transaction, the chief financial officer now owns 247,317 shares in the company, valued at $7,654,461.15. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Elizabeth Quadros Betten sold 47,531 shares of the stock in a transaction that occurred on Wednesday, August 21st. The stock was sold at an average price of $31.09, for a total value of $1,477,738.79. Following the sale, the director now owns 21,339 shares in the company, valued at $663,429.51. The disclosure for this sale can be found here. 0.64% of the stock is currently owned by insiders.
Analyst Upgrades and Downgrades
Get Our Latest Analysis on OPCH
Option Care Health Stock Down 3.7 %
Shares of OPCH opened at $30.15 on Wednesday. Option Care Health, Inc. has a 52 week low of $26.11 and a 52 week high of $34.63. The company has a debt-to-equity ratio of 0.78, a quick ratio of 1.36 and a current ratio of 1.76. The firm has a market capitalization of $5.24 billion, a P/E ratio of 19.84, a P/E/G ratio of 2.42 and a beta of 1.29. The company has a 50-day simple moving average of $31.27 and a 200-day simple moving average of $30.39.
Option Care Health (NASDAQ:OPCH – Get Free Report) last released its quarterly earnings data on Wednesday, July 31st. The company reported $0.30 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.27 by $0.03. The business had revenue of $1.23 billion for the quarter, compared to analysts’ expectations of $1.17 billion. Option Care Health had a return on equity of 14.82% and a net margin of 4.60%. Option Care Health’s quarterly revenue was up 14.8% on a year-over-year basis. During the same period in the previous year, the business posted $0.63 earnings per share. On average, equities research analysts expect that Option Care Health, Inc. will post 1.22 earnings per share for the current year.
About Option Care Health
Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.
Read More
- Five stocks we like better than Option Care Health
- What is a Bond Market Holiday? How to Invest and Trade
- Why Lennar Stock Could Be the Best Play in the Housing Market
- What is the Nikkei 225 index?
- 2 Energy Stocks Fueling the AI Datacenter Boom
- What is MarketRank™? How to Use it
- Will Marinus Pharmaceuticals Be the Next Big Winner in Biotech?
Receive News & Ratings for Option Care Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Option Care Health and related companies with MarketBeat.com's FREE daily email newsletter.